[Structural modification and bioactivity of cyclovirobuxine D]

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Cardiovascular diseases remain a leading cause of mortality worldwide.
• Cyclovirobuxine D, a natural product, has shown potential therapeutic properties.
• Structural modification is a key strategy for optimizing drug efficacy and safety.

Purpose of the Study:

• To synthesize novel cyclovirobuxine D analogues using rational drug design.
• To evaluate the cardiovascular therapeutic potential of these new compounds.
• To identify analogues with improved activity compared to cyclovirobuxine D.

Main Methods:

• Preparation of a series of cyclovirobuxine D analogues.
• Structural confirmation of synthesized compounds using spectroscopic methods.
• In vitro and/or in vivo testing of bioactivities, including endurance lacking oxygen activity and antiarrhythmia effects.

Main Results:

• Ten new cyclovirobuxine D analogues were successfully synthesized.
• The structures of the novel compounds were confirmed.
• Preliminary bioactivity screening identified promising candidates.

Conclusions:

• Several cyclovirobuxine D analogues exhibit promising endurance lacking oxygen activity.
• Some synthesized analogues demonstrated significant antiarrhythmia effects.
• These findings suggest that structural modification of cyclovirobuxine D can yield potent cardiovascular agents.